13F Data
13F filer · CIK 1346824

RA CAPITAL MANAGEMENT, L.P.

BOSTON, MA · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$11.5B
+$2.1B vs prior
Positions
84
New / sold out
17 / 18
Added / reduced
10 / 10
Turnover
33.1%
buys $4.7B · sells $3.5B
Top-10 weight
60.4%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewASCENDIS PHARMA A/S+10,281,496–+$2.7B
NewPARABILIS MEDICINES INC+28,933,371–+$791.9M
NewHEMAB THERAPEUTICS HOLDINGS+7,808,627–+$286.8M
NewABIVAX SA-ADR+1,132,557–+$150.9M
NewORUKA THERAPEUTICS INC+1,554,597–+$148.0M
AddedARTIVA BIOTHERAPEUTICS INC+8,102,340+82.2%+$78.6M
NewINTELLIA THERAPEUTICS INC+4,526,926–+$76.6M
NewDEFINIUM THERAPEUTICS INC+1,500,000–+$70.6M
NewSANA BIOTECHNOLOGY INC+18,750,000–+$65.4M
NewPRELUDE THERAPEUTICS INC+6,475,882–+$34.5M
17 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outASCENDIS PHARMA A/S - ADR-10,281,496-100.0%$-2.4B
Sold outDIANTHUS THERAPEUTICS INC-2,611,733-100.0%$-219.2M
ReducedNUVALENT INC-A-1,287,689-50.8%$-159.0M
Sold outPRAXIS PRECISION MEDICINES I-373,787-100.0%$-120.4M
Sold outSAREPTA THERAPEUTICS INC-3,902,596-100.0%$-84.9M
ReducedEDGEWISE THERAPEUTICS INC-2,035,707-19.5%$-82.7M
Sold outSPYRE THERAPEUTICS INC-1,621,620-100.0%$-81.8M
ReducedVOR BIOPHARMA INC-3,002,903-55.6%$-55.3M
Sold outFULCRUM THERAPEUTICS INC-6,053,960-100.0%$-46.4M
Sold outOLEMA PHARMACEUTICALS INC-2,600,000-100.0%$-38.8M
18 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $754.0MQ3 2013: $958.1MQ4 2013: $858.5MQ1 2014: $1.4BQ2 2014: $989.3MQ3 2014: $846.3MQ4 2014: $930.5MQ1 2015: $1.0BQ2 2015: $994.1MQ3 2015: $696.3MQ4 2015: $1.0BQ1 2016: $782.3MQ2 2016: $722.2MQ3 2016: $969.4MQ4 2016: $705.8MQ1 2017: $815.3MQ2 2017: $871.4MQ3 2017: $1.1BQ4 2017: $1.2BQ1 2018: $1.3BQ2 2018: $1.5BQ3 2018: $1.9BQ4 2018: $1.7BQ1 2019: $2.3BQ2 2019: $1.9BQ3 2019: $1.7BQ4 2019: $3.3BQ1 2020: $3.2BQ2 2020: $5.1BQ3 2020: $5.5BQ4 2020: $7.2BQ1 2021: $6.6BQ2 2021: $6.4BQ3 2021: $7.2BQ4 2021: $5.7BQ1 2022: $4.6BQ2 2022: $3.8BQ3 2022: $4.7BQ4 2022: $4.9BQ1 2023: $4.4BQ2 2023: $5.3BQ3 2023: $5.1BQ4 2023: $6.4BQ1 2024: $7.9BQ2 2024: $7.6BQ3 2024: $8.7BQ4 2024: $7.5BQ1 2025: $6.0BQ2 2025: $5.9BQ3 2025: $8.1BQ4 2025: $9.8BQ1 2026: $9.4BQ2 2026: $11.5B
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1ASCENDIS PHARMA A/SCOMMON STOCK10,281,496$2.7B23.83%
2PARABILIS MEDICINES INCCOMMON STOCK28,933,371$791.9M6.88%
3RHYTHM PHARMACEUTICALS INCCOMMON STOCK6,666,837$740.2M6.43%
4VAXCYTE INCCOMMON STOCK11,474,599$667.0M5.80%
5SIONNA THERAPEUTICS INCCOMMON STOCK9,905,045$435.7M3.79%
6TYRA BIOSCIENCES INCCOMMON STOCK12,198,625$389.6M3.39%
7EDGEWISE THERAPEUTICS INCCOMMON STOCK8,392,730$341.0M2.96%
8NEWAMSTERDAM PHARMA CO NVCOMMON STOCK9,550,191$323.7M2.81%
9HEMAB THERAPEUTICS HOLDINGSCOMMON STOCK7,808,627$286.8M2.49%
10SEPTERNA INCCOMMON STOCK6,995,858$234.3M2.04%
74 more rows. Subscribe for $29/month to see every row, download the data and use the API.